Walleye Trading LLC Cyma Bay Therapeutics, Inc. Transaction History

Walleye Trading LLC

  • $41.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$3.22 - $6.27 $7,045 - $13,718
-2,188 Reduced 8.23%
24,412 $153,000
Q3 2022

Nov 14, 2022
BUY
$2.77 - $4.25 $73,682 - $113,050
26,600 New
26,600 $93,000
Q3 2020

Nov 16, 2020
SELL
$3.32 - $7.24 $66,400 - $144,800
-20,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$1.41 - $4.25 $28,200 - $85,000
20,000 New
20,000 $70,000

Others Institutions Holding CBAY

# of Institutions
7
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email